» Articles » PMID: 34430523

A Comparative Study of Pancreas Transplantation Between Type 1 and 2 Diabetes Mellitus

Overview
Date 2021 Aug 25
PMID 34430523
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreas transplantation remains the best long-term treatment option to achieve physiological euglycemia and insulin independence in patients with labile diabetes mellitus (DM). It is widely accepted as an optimal procedure for type 1 DM (T1DM), but its application in type 2 DM (T2DM) is not unanimously acknowledged.

Methods: In total, 146 diabetes patients undergoing pancreas transplantation were included in this study. Clinical data and outcomes were compared between the T1DM and T2DM groups.

Results: Majority (93%) of the pancreas transplantations in T2DM were for uremic recipients. Complications occurred in 106 (73%) patients, including 70 (48%) with early complications before discharge and 79 (54%) with late complications during follow-up period. Overall, rejection of pancreas graft occurred in 37 (25%) patients. Total rejection rate in T2DM recipients was significantly lower than that in T1DM. The short- and long-term outcomes for endocrine function in terms of fasting blood sugar and hemoglobin A1c levels and graft survival rates are comparable between the T2DM and T1DM groups.

Conclusions: T2DM is not inferior to T1DM after pancreas transplantation in terms of surgical risks, immunological and endocrine outcomes, and graft survival rates. Therefore, pancreas transplantation could be an effective option to treat selected uremic T2DM patients without significant insulin resistance.

References
1.
Chakkera H, Bodner J, Heilman R, Mulligan D, Moss A, Mekeel K . Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus. Transplant Proc. 2010; 42(7):2650-2. PMC: 3060052. DOI: 10.1016/j.transproceed.2010.04.065. View

2.
Al-Qaoud T, Odorico J, Redfield 3rd R . Pancreas transplantation in type 2 diabetes: expanding the criteria. Curr Opin Organ Transplant. 2018; 23(4):454-460. DOI: 10.1097/MOT.0000000000000553. View

3.
Margreiter C, Resch T, Oberhuber R, Aigner F, Maier H, Sucher R . Combined pancreas-kidney transplantation for patients with end-stage nephropathy caused by type-2 diabetes mellitus. Transplantation. 2013; 95(8):1030-6. DOI: 10.1097/TP.0b013e3182861945. View

4.
Kandaswamy R, Stock P, Gustafson S, Skeans M, Curry M, Prentice M . OPTN/SRTR 2015 Annual Data Report: Pancreas. Am J Transplant. 2017; 17 Suppl 1:117-173. DOI: 10.1111/ajt.14125. View

5.
Gruessner A, Laftavi M, Pankewycz O, Gruessner R . Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry. Curr Diab Rep. 2017; 17(6):44. DOI: 10.1007/s11892-017-0864-5. View